Cargando…
p21-activated kinase group II small compound inhibitor GNE-2861 perturbs estrogen receptor alpha signaling and restores tamoxifen-sensitivity in breast cancer cells
Estrogen receptor alpha (ERα) is highly expressed in most breast cancers. Consequently, ERα modulators, such as tamoxifen, are successful in breast cancer treatment, although tamoxifen resistance is commonly observed. While tamoxifen resistance may be caused by altered ERα signaling, the molecular m...
Autores principales: | Zhuang, Ting, Zhu, Jian, Li, Zhilun, Lorent, Julie, Zhao, Chunyan, Dahlman-Wright, Karin, Strömblad, Staffan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791272/ https://www.ncbi.nlm.nih.gov/pubmed/26554417 |
Ejemplares similares
-
p21-activated kinase 4 interacts with integrin αvβ5 and regulates αvβ5-mediated cell migration
por: Zhang, Hongquan, et al.
Publicado: (2002) -
Estrogen receptor β: an overview and update
por: Zhao, Chunyan, et al.
Publicado: (2008) -
Blockade of the Hedgehog pathway downregulates estrogen receptor alpha signaling in breast cancer cells
por: Diao, Yumei, et al.
Publicado: (2016) -
GNE genotype explains 20% of phenotypic variability in GNE myopathy
por: Pogoryelova, Oksana, et al.
Publicado: (2019) -
Estrogen Signalling and the Metabolic Syndrome: Targeting the Hepatic Estrogen Receptor Alpha Action
por: Matic, Marko, et al.
Publicado: (2013)